Antipsychotic polypharmacy, part 2: tips on use and misuse
Stahl, S.M.
Journal of Clinical Psychiatry 60(8): 506-507
1999
ISSN/ISBN: 0160-6689 PMID: 10498453 Document Number: 506776
Document emailed within 1 workday
Related Documents
Jakovljević, M. 2013: How to increase treatment effectiveness and efficiency in psychiatry: creative psychopharmacotherapy - part 1: definition, fundamental principles and higher effectiveness polypharmacy Psychiatria Danubina 25(3): 269-273Diurni, M.; Baranzini, F.; Costantini, C.; Poloni, N.; Vender, S.; Callegari, C. 2009: Metabolic side effects of second generation antipsychotic agents in antipsychotic-naïve patients: preliminary study Recenti Progressi in Medicina 100(2): 103
Chong, S.-A.; Ravichandran, N.; Poon, L.-Y.; Soo, K.-L.; Verma, S. 2006: Reducing polypharmacy through the introduction of a treatment algorithm: use of a treatment algorithm on the impact on polypharmacy Annals of the Academy of Medicine Singapore 35(7): 457-460
Allen, L.V. 2014: Basics of compounding: tips and hints, part 6: Prescription evaluation, calculations, ingredients, quality-assurance practices, patient counseling, shipping and distribution, miscellaneous International Journal of Pharmaceutical Compounding 18(6): 486-488
Dufresne, R.L.; Wagner, R.L. 1988: Antipsychotic-withdrawal akathisia versus antipsychotic-induced akathisia: further evidence for the existence of tardive akathisia Journal of Clinical Psychiatry 49(11): 435-438
Shakib, S. 2002: Problems of polypharmacy Australian Family Physician 31(2): 125-128
Ryan, F. 1987: Polytherapy not polypharmacy Medical Journal of Australia 147(6): 316
Shepherd, M. 1998: The risks of polypharmacy Nursing Times 94(32): 60-62
Dunn, H.P. 1986: Polypharmacy record New Zealand Medical Journal 99(810): 728
Leppik, I.E. 2000: Monotherapy and polypharmacy Neurology 55(11 Suppl. 3): S25-S29
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Myers, L.W.; Phillips, J.T. 1996: Polypharmacy in multiple sclerosis Epilepsy Research. Suppl 11: 181-195
Madan, B.R. 1971: Polypharmacy--more sinning than sinned against Indian Journal of Physiology and Pharmacology 15(3): 87-91
Terplan, M. 1993: Polypharmacy in skilled-nursing facilities Annals of Internal Medicine 118(8): 650; Author Reply 650-1
Greenleaf Brown, L. 2016: Untangling Polypharmacy in Older Adults Medsurg Nursing: Official Journal of the Academy of Medical-Surgical Nurses 25(6): 408-411
Freudenreich, O.; Goff, D.C. 2003: Polypharmacy in schizophrenia: a fuzzy concept Journal of Clinical Psychiatry 64(9): 1132; Author Reply 1132-3
Mullen, P.A. 1977: Milk fever: a case against polypharmacy solutions Veterinary Record 101(20): 405-407
Rajska-Neumann, A.; Szymański, Mł.; Balcer, N.; Grześkowiak, E.; Szałek, E.; Wieczorowska-Tobis, K. 2005: Is smoking a determinant of polypharmacy among elderly subject? Przeglad Lekarski 62(10): 1145-1147
Thomas, D.R. 1991: "The brown bag" and other approaches to decreasing polypharmacy in the elderly North Carolina Medical Journal 52(11): 565-566
Cleland, J.G.; Baksh, A.; Louis, A. 2000: Polypharmacy (or polytherapy) in the treatment of heart failure Heart Failure Monitor 1(1): 8-13